

"Bioanalytical systems that unlock complex biology and accelerate life science discovery"
Molecular Devices designs bioanalytical systems for life science research and drug discovery. The company provides microplate readers, cellular imaging systems, colony pickers, and automated workflows that analyse complex biology, from 3D models to high throughput screening. Pharmaceutical companies, biotech firms, academia, and government labs use these instruments to advance therapeutic development. Modern drug discovery demands human relevant models beyond 2D cultures. Molecular Devices combines advanced hardware, AI enabled analysis, and automation into integrated solutions. This allows researchers to scale complex biology studies with greater reproducibility, shortening the path from discovery to therapies that reach patients.


1200
Team Members
1983
Founded
Medical Devices
Sector
Hybrid
Work Environment
A world where life science researchers have seamless access to human relevant models and AI driven tools, enabling discoveries that translate directly into safer, more effective therapies and improved quality of life for patients everywhere.
Helping scientists harness the full potential of biology by providing advanced bioanalytical systems and automated workflows that empower transformational breakthroughs in drug discovery and therapeutic development.